PROTEASE-INHIBITOREN
European patent · EP2331548 · In force
Register entry
- Publication number
- EP2331548
- Application number
- EP09783391
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 24, 2009
- Published
- Jun 15, 2011
- Granted
- Sep 4, 2013
- Protection ends at the latest
- Sep 23, 2029
- Next annual fee due
- Sep 30, 2027
- IPC classes
- C07D 491/048 (2006.01)A61K 31/496 (2006.01)A61P 19/00 (2006.01)
- Priority
- GB 0817424 24.09.2008
- PCT application
- PCT/EP2009/062406 24.09.2009
- PCT publication
- WO2010/034788 01.04.2010
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Apr 9, 2025
Agent removed
- Representative
- Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano (removed)
Published in Swissreg on 09.04.2025
- Apr 9, 2025
Agent entered
- Representative
- PRAXI Intellectual Property SA, Via San Gottardo 15, 6900 Lugano
Published in Swissreg on 09.04.2025
- Oct 3, 2024
Change
Published in Swissreg on 03.10.2024
- Oct 1, 2023
Change
Published in Swissreg on 01.10.2023
- Oct 1, 2022
Change
Published in Swissreg on 01.10.2022
- Oct 23, 2013
Agent entered
- Representative
- Fiammenghi-Fiammenghi, Via San Gottardo 15, 6900 Lugano
Published in Swissreg on 23.10.2013
1 earlier entry
- Sep 4, 2013
Granted
Published in Swissreg on 04.09.2013
Parties
Inventor
S-141 22 Huddinge, SE
S-141 22 Huddinge, SE
S-141 22 Huddinge, SE
S-141 22 Huddinge, SE
Essex CB10 1XL, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.